Hospital
Uhs-Corona INC
Uhs-Corona INC was paid $35.18M by Medicaid between Jan 2018 and Dec 2024, across 261 billing codes. Its largest line is 0450, Emergency room services — 13% of everything it billed.
33Billing provider infoUHS-CORONA INC
CORONA, CA 92882
CORONA, CA 92882
33aNPI1457347239assigned 09/27/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$35.18M
24GClaims1,126,562
24DCodes billed261
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#84 of 410
Median peer was paid$6.90M
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 164,196 | $4.51M | |
| 2019 | 190,993 | $5.00M | |
| 2020 | 120,885 | $3.37M | |
| 2021 | 138,548 | $4.57M | |
| 2022 | 170,538 | $5.80M | |
| 2023 | 184,115 | $6.32M | |
| 2024incomplete | 157,287 | $5.61M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 13% | 83,846 | 72,631 | $4.43M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.8% | 52,641 | 46,460 | $3.08M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.7% | 6,165 | 5,952 | $2.01M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.1% | 20,118 | 18,114 | $1.79M |
| L8699 | Prosthetic implant, not otherwise specified | 4.1% | 925 | 833 | $1.44M |
| 93975 | 3.6% | 3,881 | 3,672 | $1.26M | |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 9,616 | 9,259 | $1.11M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.0% | 6,463 | 6,246 | $1.07M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.9% | 19,308 | 2,703 | $1.01M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 29,508 | 26,229 | $887K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 21,653 | 19,732 | $885K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.4% | 14,064 | 12,350 | $848K |
249 more codes
| 80053 | Comprehensive metabolic panel | 2.0% | 58,977 | $721K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 7,450 | $613K |
| Z7502 | 1.7% | 16,000 | $607K | |
| 99499 | 1.6% | 5,141 | $576K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 66,217 | $556K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 29,878 | $505K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 4,319 | $447K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.2% | 13,131 | $440K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.2% | 1,471 | $411K |
| 99285 | Emergency room visit (most serious) | 1.1% | 2,822 | $381K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.1% | 13,120 | $380K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,756 | $330K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,097 | $328K |
| 0710 | <1% | 3,756 | $317K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,920 | $306K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 4,234 | $293K |
| 84484 | <1% | 25,416 | $278K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,608 | $256K |
| 99221 | <1% | 1,337 | $245K | |
| 93971 | <1% | 1,838 | $245K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,760 | $236K |
| 99284 | Emergency room visit (serious) | <1% | 2,576 | $230K |
| 76801 | <1% | 2,557 | $220K | |
| 0762 | <1% | 943 | $186K | |
| 93307 | <1% | 1,210 | $182K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,620 | $180K |
| 83880 | <1% | 5,551 | $176K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 940 | $163K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,706 | $161K |
| 83690 | <1% | 20,581 | $159K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,258 | $147K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 5,843 | $137K |
| 99070 | <1% | 60,955 | $131K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,604 | $129K |
| 87276 | <1% | 13,268 | $120K | |
| 84703 | <1% | 12,891 | $113K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12,221 | $105K |
| 59425 | <1% | 1,631 | $104K | |
| 87275 | <1% | 13,271 | $100K | |
| J3490 | Unclassified drugs | <1% | 42,923 | $100K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,390 | $99K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,947 | $98K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 8,703 | $98K |
| 81001 | <1% | 24,350 | $88K | |
| 73130 | <1% | 2,636 | $83K | |
| 73630 | <1% | 2,883 | $82K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 949 | $82K |
| 87641 | <1% | 2,902 | $82K | |
| 73610 | <1% | 2,660 | $81K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,042 | $81K |
| 84702 | <1% | 4,536 | $78K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,774 | $76K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,355 | $75K |
| 93970 | <1% | 312 | $74K | |
| 0510 | <1% | 2,602 | $72K | |
| 73562 | <1% | 2,572 | $71K | |
| 73030 | <1% | 2,298 | $68K | |
| 90715 | <1% | 2,010 | $67K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,218 | $67K |
| 82962 | <1% | 13,679 | $65K | |
| 83605 | <1% | 5,648 | $62K | |
| 87040 | <1% | 5,691 | $61K | |
| 73110 | <1% | 1,906 | $61K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,586 | $60K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,300 | $60K |
| 72100 | <1% | 1,694 | $56K | |
| 88341 | <1% | 933 | $54K | |
| 59025 | Fetal non-stress test | <1% | 3,352 | $52K |
| 87430 | <1% | 4,382 | $50K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 2,707 | $49K |
| 81025 | <1% | 8,718 | $49K | |
| Z7610 | <1% | 4,087 | $48K | |
| 88342 | <1% | 1,639 | $47K | |
| 85730 | <1% | 7,481 | $45K | |
| 87186 | <1% | 4,570 | $45K | |
| 81003 | <1% | 17,175 | $44K | |
| 85610 | <1% | 10,712 | $43K | |
| 85379 | <1% | 3,344 | $39K | |
| 87077 | <1% | 4,783 | $38K | |
| 0353U | <1% | 409 | $38K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 407 | $37K |
| 87070 | <1% | 3,142 | $37K | |
| 70496 | <1% | 132 | $37K | |
| 93976 | <1% | 128 | $37K | |
| 0272 | <1% | 347 | $37K | |
| 73080 | <1% | 1,150 | $36K | |
| 83735 | <1% | 5,205 | $35K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 8,079 | $33K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 20,662 | $33K |
| 74018 | <1% | 1,151 | $32K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 131 | $31K |
| J2704 | Injection, propofol, 10 mg | <1% | 7,670 | $30K |
| G0378 | Hospital observation service, per hour | <1% | 432 | $28K |
| 12001 | <1% | 1,052 | $27K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 522 | $26K |
| 70486 | <1% | 208 | $26K | |
| 87420 | <1% | 4,930 | $26K | |
| 0250 | <1% | 3,721 | $25K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 772 | $22K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 763 | $22K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 614 | $21K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 433 | $21K |
| 72131 | <1% | 145 | $20K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,682 | $20K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,104 | $20K |
| 12011 | <1% | 556 | $19K | |
| 70498 | <1% | 121 | $19K | |
| 73502 | <1% | 465 | $19K | |
| 73590 | <1% | 778 | $18K | |
| 86901 | <1% | 4,692 | $18K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 412 | $18K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 238 | $18K |
| 73090 | <1% | 707 | $17K | |
| 86850 | <1% | 2,818 | $17K | |
| 87081 | <1% | 2,173 | $17K | |
| 72040 | <1% | 597 | $17K | |
| 84439 | <1% | 1,720 | $16K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 388 | $16K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14,146 | $16K |
| 86900 | <1% | 4,692 | $15K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,151 | $15K |
| 88312 | <1% | 1,361 | $15K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 153 | $15K |
| 76870 | <1% | 226 | $14K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 551 | $13K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 547 | $13K |
| 86140 | <1% | 2,278 | $13K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,080 | $13K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 233 | $12K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,251 | $11K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 278 | $11K |
| 85027 | <1% | 1,554 | $11K | |
| 71020 | <1% | 281 | $11K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 182 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,201 | $10K |
| 99199 | Unlisted special service, procedure or report | <1% | 228 | $10K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,717 | $10K |
| 82550 | <1% | 1,359 | $10K | |
| 70491 | <1% | 39 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 84 | $9K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 87 | $8K |
| 82803 | <1% | 497 | $8K | |
| 99217 | <1% | 266 | $8K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,035 | $8K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 4,036 | $8K |
| 80061 | Lipid panel | <1% | 774 | $7K |
| 99218 | <1% | 45 | $7K | |
| 96367 | <1% | 108 | $7K | |
| 29125 | <1% | 376 | $7K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,126 | $7K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,173 | $6K |
| 96376 | <1% | 284 | $6K | |
| 0270 | <1% | 3,749 | $6K | |
| 97597 | <1% | 161 | $6K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 105 | $6K |
| 87205 | <1% | 1,159 | $6K | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 135 | $6K |
| 86677 | <1% | 296 | $5K | |
| 84145 | <1% | 243 | $5K | |
| 76642 | <1% | 86 | $5K | |
| 71101 | <1% | 153 | $5K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 189 | $5K |
| 85652 | <1% | 1,647 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 24 | $5K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,311 | $4K |
| 84100 | <1% | 1,054 | $4K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 3,917 | $4K |
| 87899 | <1% | 471 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,918 | $4K |
| 10060 | <1% | 166 | $4K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 665 | $4K |
| C1769 | Guide wire | <1% | 38 | $3K |
| 81002 | <1% | 1,078 | $3K | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 227 | $3K |
| G0410 | Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | <1% | 168 | $3K |
| 88313 | <1% | 241 | $3K | |
| 12002 | <1% | 80 | $3K | |
| 29515 | <1% | 217 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 727 | $3K |
| 76775 | <1% | 44 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,905 | $2K |
| 70360 | <1% | 97 | $2K | |
| 47562 | <1% | 13 | $2K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 17 | $2K |
| 0360 | <1% | 19 | $2K | |
| 71010 | <1% | 86 | $2K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 170 | $2K |
| 74022 | <1% | 45 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $2K |
| 82140 | <1% | 126 | $2K | |
| 86703 | <1% | 101 | $2K | |
| 80076 | <1% | 190 | $2K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,598 | $1K |
| 77066 | Tomosynthesis, mammo | <1% | 16 | $1K |
| 73140 | <1% | 84 | $1K | |
| 59430 | <1% | 25 | $1K | |
| 82150 | <1% | 184 | $1K | |
| 87075 | <1% | 131 | $1K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 443 | $1K |
| 93017 | <1% | 29 | $1K | |
| 88304 | <1% | 101 | $1K | |
| 87210 | <1% | 255 | $1K | |
| 0370 | <1% | 34 | $1K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 29 | $1K |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 317 | $1K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 55 | $1K |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 61 | $963.88 |
| 72072 | <1% | 25 | $880.21 | |
| A9270 | Non-covered item or service | <1% | 2,119 | $854.98 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 590 | $820.34 |
| 77001 | <1% | 13 | $818.97 | |
| 99224 | <1% | 12 | $771.72 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 159 | $702.60 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 15 | $696.50 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 99 | $692.64 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 28 | $626.40 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 78 | $619.84 |
| 82375 | <1% | 41 | $557.10 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 13 | $461.61 |
| 73060 | <1% | 16 | $426.92 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 72 | $408.88 |
| 82274 | <1% | 27 | $387.75 | |
| 87320 | <1% | 27 | $353.50 | |
| 83050 | <1% | 42 | $350.15 | |
| 73552 | <1% | 15 | $338.08 | |
| 74000 | <1% | 13 | $335.45 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 130 | $329.56 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 355 | $327.98 |
| 86592 | <1% | 69 | $314.56 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 28 | $289.27 |
| 82810 | <1% | 27 | $281.06 | |
| 73620 | <1% | 14 | $265.51 | |
| 82553 | <1% | 21 | $263.78 | |
| 82010 | <1% | 26 | $235.75 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 13 | $221.85 |
| 82728 | <1% | 13 | $215.13 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 73 | $193.68 |
| 90686 | <1% | 18 | $175.73 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 52 | $166.21 |
| 76937 | <1% | 12 | $159.35 | |
| 86308 | <1% | 27 | $153.01 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 113 | $98.07 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 18 | $85.13 |
| 84550 | <1% | 12 | $66.93 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 64 | $55.61 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 55 | $53.39 |
| 36600 | <1% | 13 | $47.39 | |
| 85007 | <1% | 13 | $39.98 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | <1% | 14 | $36.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (CFO, SENIOR VP)
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
| Friends Behavioral Health System, LP | Philadelphia, PA | $9.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.